All In Biotech

Drug Trial Radar · NCT01806610

Study of Safety and Tolerability of BPS804 in Patients With Late-stage Chronic Kidney Disease

A Randomized, Placebo-controlled Trial of BPS804 on Safety and Tolerability in Patients With Late-stage Chronic Kidney Disease

Last checked: Nov 19, 2026Latest source record: Sep 14, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Aug 2013

Primary completion

Apr 2014

Study completion Apr 2014

Sponsor

Lead sponsor
Ultragenyx Pharmaceutical IncIndustry
Sponsor type
Industry
Collaborators
Mereo BioPharma; Novartis
First posted
Mar 7, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to evaluate the safety, tolerability, and PK following a single administration of BPS804 in patients with chronic kidney disease stage 5D (CKD-5D) on hemodialysis.

Conditions

  • Chronic-kidney Disease Stage 5D on Stable Hemodialysis

Interventions

  • BPS804Drug

    Single dose BPS804 administration.

  • PlaceboDrug

    Single dose placebo administration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Occurrence of adverse events after a single administration of BPS804Time frame: 17 weeks

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.